表紙
市場調查報告書

動物治療藥及診斷藥全球市場

Global Markets for Animal Therapeutics and Diagnostics

出版商 BCC Research 商品編碼 242225
出版日期 內容資訊 英文 274 Pages
訂單完成後即時交付
價格
動物治療藥及診斷藥全球市場 Global Markets for Animal Therapeutics and Diagnostics
出版日期: 2020年02月07日內容資訊: 英文 274 Pages
簡介

預估全球動物治療藥及診斷藥市場將以5.9%的CAGR推移,從2019年的499億美元於2024年成長至665億美元規模。預估治療藥部門於期間內將以6.2%的CAGR推移,從2019年的199億美元於2024年成長至269億美元規模;診斷藥部門於期間內將以7.9%的CAGR推移,從2019年的40億美元於2024年成長至58億美元規模。

本報告研究全球動物治療藥及診斷藥市場,彙整市場及技術背景、監管環境,提供按產品類型、動物區分、地區/主要國家的趨勢和市場規模推移預測,以及影響市場成長的各種因素及市場機會分析、競爭環境、主要企業簡介等情報。

第1章 前言

第2章 摘要與重點

  • 市場概要

第3章 市場及技術背景

  • 動物解剖與生理學
  • 美國動物族群
  • 伴侶寵物飼養趨勢
  • 獸醫服務產業需求
  • 法律和監管問題
  • 動物健康中的生物科技
  • 動物複製
  • 益生菌
  • 動物肥胖
  • 減重
  • 尖端醫療程序
  • 生命週期方式
  • 全球動物治療藥和診斷藥市場分析
  • 市場:按應用或動物分類
  • 市場:按地區
  • 競爭分析

第4章 動物疫苗市場

  • 概要
  • 全球市場分析與考察
  • 全球市場:按地區
  • 競爭概要
  • 產品介紹
    • 自動免疫
    • 被動免疫
    • 其他
  • 伴侶寵物
    • 病毒
    • 疫苗提供商
  • 伴侶寵物疫苗市場分析
  • 生產動物
    • 病毒和病原性蛋白顆粒
  • 疫苗提供商
    • Bayer
    • Boehringer Ingelheim
    • Dechra Pharmaceuticals
    • Elanco
  • 生產動物疫苗市場分析

第5章 動物治療藥市場

  • 概要
  • 全球市場分析與考察
  • 伴侶寵物市場 vs 生產動物市場
  • 競爭概要
  • 產品介紹
    • 過敏和呼吸系統藥物
    • 伴侶寵物:過敏和發炎性疾病
    • 標靶物種和提供商
    • 市場分析
  • 抗感染藥和抗真菌藥
    • 伴侶寵物:細菌感染
    • 生產動物:細菌感染
    • 提供商
    • 市場分析
  • 消炎藥和鎮痛藥
    • 提供商
    • 市場分析
  • 代謝和內分泌失調藥物
    • 代謝性疾病和內分泌失調
    • 提供商
    • 市場分析
  • 殺寄生蟲藥
    • 伴侶寵物:寄生蟲病
    • 生產動物:寄生蟲病案例
    • 提供商
    • 殺蟲劑市場分析
  • 精神科藥物
    • 提供商
    • 自然療法
    • 市場分析
  • 其他醫藥品
    • 伴侶寵物:其他疾病
    • 提供商
    • 牙科
  • 其他醫藥品市場分析

第6章 動物飼料添加物市場

  • 概要
  • 全球市場分析與考察
  • 伴侶寵物市場 vs 生產動物市場
  • 市場:按地區
  • 競爭概要
  • 胺基酸
    • 提供商
    • 市場分析
  • 藥用添加物
    • 提供商
    • 市場分析
  • 營養補充劑
    • 提供商
    • 市場分析
  • 維生素和礦物質
    • 提供商
    • 市場分析

第7章 動物診斷藥市場

  • 概要
  • 全球市場分析與結論
  • 伴侶寵物市場 vs 生產動物市場
  • 市場:按地區
  • 競爭概要
  • 診斷檢測概要
  • 產品提供商
    • Bayer
    • Bayer
    • Bayer
    • Bayer
    • IDEXX
    • Merck Animal Health
    • Zoetis
  • 產品分類
  • 迅速診斷檢測市場分析
  • 診斷分析裝置和耗材市場分析
  • 診斷影像設備市場分析

第8章 技術評估

  • 概要
  • 藥物傳輸創新
    • 經皮(Spray-on)藥
    • On-Site檢測和治療
    • 發泡錠疫苗傳輸
  • 專利趨勢

第9章 企業簡介

  • 概要
  • 簡介
    • AJINOMOTO CO., INC.
    • ALLTECH
    • ARATANA THERAPEUTICS INC.
    • BASF ANIMAL NUTRITION
    • BAYER ANIMAL HEALTH GMBH
    • BLUESTAR ADISSEO CO., LTD.
    • BOEHRINGER INGELHEIM VETMEDICA INC.
    • DECHRA PHARMACEUTICALS PLC
    • DSM NUTRITIONAL PRODUCTS LTD.
    • ELANCO ANIMAL HEALTH INC.
    • EVONIK INDUSTRIES AG
    • HESKA CORP.
    • IDEXX LABORATORIES INC.
    • MERCK ANIMAL HEALTH
    • MOSAIC CO. (THE)
    • VIRBAC S.A.
    • ZOETIS INC.

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC034F

Report Highlights:

The global animal therapeutics and diagnostics market should grow from $49.9 billion in 2019 to $66.5 billion by 2024 with a compound annual growth rate (CAGR) of 5.9% for the period of 2019-2024.

The global animal therapeutics (or pharmaceuticals segment) market should grow from $19.9 billion in 2019 to $26.9 billion by 2024 with a CAGR of 6.2% for the period of 2019-2024.

The global animal diagnostic products market should grow from $4.0 billion in 2019 to $5.8 billion by 2024 with a CAGR of 7.9% for the period of 2019-2024.

Report Scope:

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries, and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.

Report Includes:

  • 64 data tables and 109 additional tables
  • Brief overview of the global market for animal therapeutics and diagnostics within the industry
  • Analyses of the global market trends, with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Assessment of factors driving the industry's growth, current trends, market opportunities and restraints, and technological advancements that will shape and influence the future marketplace
  • Evaluation of the market size corresponding to total production of animal healthcare products, vaccines, feed additives, therapeutic and diagnostic drugs; their growth forecasts and industry trends
  • Market share analysis of the leading animal vaccines and therapeutic drug suppliers; their key Competitive landscape, market positioning, revenue sales, and product segments
  • Patent study and analysis covering significant allotments of the U.S. patents granted on animal health products
  • Detailed company profiles of the market leading participants. Major players included BASF Animal Nutrition, Bayer Animal Health GmbH, DSM Nutritional Products Ltd., Evonik Industries AG, Merck Animal Health and Mosaic Co.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Overview
    • Leading Manufacturers and Suppliers
    • Trends Driving the Animal Health Industry

Chapter 3: Market and Technology Background

  • Animal Anatomy and Physiology
    • Reproductive System
    • Avian Anatomy
  • Animal Populations in the United States
    • Companion Animals
    • Food Production Animals
    • Meat Consumption
    • Animal Populations by Country
  • Trends in Companion Pet Ownership
    • Animal Health Insurance
  • Demand in the Veterinary Service Industry
  • Legal and Regulatory Issues
    • Regulatory Agencies Involved in Animal Health and Welfare
    • Antibiotic Use and Resistance in Production Animals
    • Levels of Contaminated Meats in the U.S.
    • Movement for Lower Amounts of Antibiotics in Livestock Production
    • Minimally and Highly Regulated Products
    • Animal Drug User Fee Act of 2003
    • Animal Drug User Fee Amendments of 2008 (ADUFA II)
    • Animal Drug User Fee Amendments of 2013 (ADUFA III)
    • Animal Drug User Fee Amendments of 2018 (ADUFA III)
    • Zoonotic Diseases
  • Biotechnology in Animal Health
  • Animal Cloning
  • Probiotics
  • Animal Obesity
    • Causes
  • Weight Reduction
  • Advanced Medical Procedures
  • Life Cycle Approach
  • Global Animal Therapeutics and Diagnostics Market Analysis
  • Markets by Use or Animal Group
  • Markets by Geographic Region
  • Competitive Analysis

Chapter 4: Animal Vaccine Markets

  • Overview
  • Global Market Analysis and Considerations
  • Global Market by Geographical Region
  • Competitive Summary
  • Product Introduction
    • Active Immunity
    • Passive Immunity
    • Other Types
  • Companion Animals
    • Viruses
    • Vaccine Providers
  • Companion Animal Vaccines Market Analysis
  • Production Animals
    • Viruses and Prions
  • Vaccine Providers
    • Bayer
    • Boehringer Ingelheim
    • Dechra Pharmaceuticals
    • Elanco
  • Production Animal Vaccine Market Analysis

Chapter 5: Animal Pharmaceuticals and Therapies Market

  • Overview
  • Global Market Analysis and Considerations
  • Companion Animal vs. Production Animal Markets
    • Markets by Geographical Region
  • Competitive Summary
  • Product Introductions
    • Allergy and Respiratory Drugs
    • Companion Animals: Allergy and Inflammatory Diseases
    • Target Species and Providers
    • Allergy and Respiratory Market Analysis
  • Anti-Infectives and Antifungals
    • Companion Animals - Bacterial Infections
    • Production Animals - Bacterial Infections
    • Providers
    • Anti-Infectives Market Analysis
  • Anti-Inflammatories and Analgesics
    • Providers
    • Anti-Inflammatory and Analgesic Market Analysis
  • Metabolic and Endocrine Disorder Drugs
    • Metabolic Diseases and Endocrine Disorders
    • Providers
    • Metabolic Drug Market Analysis
  • Parasiticides
    • Companion Animals - Parasitic Diseases
    • Production Animals - Parasitic Disease Example
    • Providers
    • Parasiticide Market Analysis
  • Psychotropic Medications
    • Providers
    • Natural Remedies
    • Psychotropic Market Analysis
  • Other Pharmaceuticals
    • Companion Animals - Other Diseases
    • Providers
    • Dental
  • Other Pharmaceuticals Market Analysis

Chapter 6: Animal Feed Additives Market

  • Overview
  • Global Market Analysis and Considerations
  • Companion Animal vs. Production Animal Markets
  • Markets by Geographical Region
  • Competitive Summary
  • Amino Acids
    • Providers
    • Amino Acid Market Analysis
  • Medicinal Additives
    • Providers
    • Medicinal Feed Additive Market Analysis
  • Nutritional Supplements
    • Providers
    • Nutritional Supplement Market Analysis
  • Vitamins and Minerals
    • Providers
    • Vitamin and Mineral Market Analysis

Chapter 7: Animal Diagnostic Markets

  • Overview
  • Global Market Analysis and Conclusion
  • Companion Animal vs. Production Animal Markets
  • Markets by Geographical Region
  • Competitive Summary
  • Diagnostic Test Descriptions
    • Centralized and Decentralized Laboratory Tests
    • Diagnostic Imaging
  • Product Providers
    • Bayer
    • Beaphar
    • Elanco
    • Heska
    • IDEXX
    • Merck Animal Health
    • Zoetis
  • Product Segments
  • Diagnostic Rapid Testing Market Analysis
  • Market Analysis of Diagnostic Analyzers and Consumables
  • Market Analysis of Diagnostic Imaging Equipment

Chapter 8: Technology Evaluation

  • Overview
  • Innovation in Drug Delivery
    • Transdermal (Spray-on) Drugs
    • On-Site Detection and Therapy
    • Effervescent Tablet Vaccine Delivery
  • Patent Product Segments
  • Patents Filed by Year
  • International Patents by Country
  • Patents Issued by Patent Holder

Chapter 9: Company Profiles

  • Overview
  • Profiles
    • AJINOMOTO CO., INC.
    • ALLTECH
    • ARATANA THERAPEUTICS INC.
    • BASF ANIMAL NUTRITION
    • BAYER ANIMAL HEALTH GMBH
    • BLUESTAR ADISSEO CO., LTD.
    • BOEHRINGER INGELHEIM VETMEDICA INC.
    • DECHRA PHARMACEUTICALS PLC
    • DSM NUTRITIONAL PRODUCTS LTD.
    • ELANCO ANIMAL HEALTH INC.
    • EVONIK INDUSTRIES AG
    • HESKA CORP.
    • IDEXX LABORATORIES INC.
    • MERCK ANIMAL HEALTH
    • MOSAIC CO. (THE)
    • VIRBAC S.A.
    • ZOETIS INC.

Chapter 10: Appendix

List of Tables

  • Table A: Major Countries, by Region
  • Summary Table: Global Market for Animal Therapeutics and Diagnostics, by Product Type, Through 2024
    • Table 1: Gestation Periods of Selected Common Species
    • Table 2: Lifespan of Common Species Birds
    • Table 3: Statistics for Companion Animals Found in U.S. Households, 2011, 2014, 2016, and 2019
    • Table 4: Estimated Populations of Companion Animals Found in U.S. Households, 2014, 2016, and 2019
    • Table 5: Population of Food Production Animals in the United States, Reported Year-End 2005, 2010, 2014, 2016, and 2018
    • Table 6: Top Broiler-Producing States in the U.S., 2018
    • Table 7: Top Red Meat Producing States in the U.S., 1990 and 2015
    • Table 8: Beef and Veal Consumption, by Country, Through 2025
    • Table 9: Pork Consumption, by Country, Through 2025
    • Table 10: Poultry Consumption, by Country, Through 2025
    • Table 11: Lamb/Mutton Consumption, by Country, Through 2025
    • Table 12: Dog (Canine) Population, by Select Country, 2018 and 2019
    • Table 13: Cat (Feline) Population, by Select Country, 2018 and 2019
    • Table 14: Horse (Equine) Population, by Country, 2018 and 2019
    • Table 15: Cattle (Bovine) Population, by Country, 2018
    • Table 16: Pig/Hog (Swine) Population, by Country, 2018
    • Table 17: Sheep Population, by Country, 2018
    • Table 18: Goat Population, by Country, 2018
    • Table 19: Broiler Population, by Country, 2018
    • Table 20: Layer Population, by Country, 2018
    • Table 21: Basic Annual Spending on Dogs and Cats in the U.S., APPA National Pet Owners Survey, 2019
    • Table 22: Pet Insurance Plan Comparisons in the United States
    • Table 23: Number of Veterinarians and Paraveterinarian Assistants, by Top 10 Countries, 2012, 2015 and 2018
    • Table 24: Estimated Number of U.S. Private Veterinary Practices, by Type of Practice, 2013, 2015 and 2018
    • Table 25: Estimated Number of Veterinarians in the United States, by Gender*, 2010-2018
    • Table 26: Affected Pioneer, Generic and Combination Antimicrobials Used in the U.S. Food-Producing Animals (Updated April 1, 2019)
    • Table 27: Domestic Antimicrobial Drug Use and Sales in Food-Producing Animals, 2010-2017
    • Table 28: Common Examples of Zoonotic Diseases
    • Table 29: Global Market for Animal Therapeutics and Diagnostics, by Product Segment, Through 2024
    • Table 30: Global Market for Animal Therapeutics and Diagnostics, by Animal Group, Through 2024
    • Table 31: Global Market for Animal Therapeutics and Diagnostics, by Geographic Region, Through 2024
    • Table 32: Global Market Shares and Revenue of Animal Therapeutics and Diagnostics, by Manufacturer, 2019
    • Table 33: Global Market for Animal Vaccines, by Animal Group, Through 2024
    • Table 34: Global Market for Animal Vaccines, by Geographic Region, Through 2024
    • Table 35: Global Market Shares of Animal Vaccine Suppliers Based on Competitor Revenues, 2019
    • Table 36: Hendra Virus Equine Incidents, 1994-2019
    • Table 37: Boehringer Ingelheim's Companion Animal Vaccines, by Target Species
    • Table 38: Elanco's Companion Animal Vaccines, by Target Species, 2019
    • Table 39: Merck's Companion Animal Vaccines, by Target Species, 2019
    • Table 40: Zoetis' Companion Animal Vaccines, by Target Species, 2019
    • Table 41: CSF-Free Countries, OIE Member Countries, as of May 2019
    • Table 42: Bayer's Production Animal Vaccines, by Target Species
    • Table 43: Boehringer Ingelheim's Production Animal Vaccines, by Target Species, 2019
    • Table 44: Elanco's Production Animal Vaccines, by Target Species, 2019
    • Table 45: Merck's Production Animal Vaccines, by Target Species, 2019
    • Table 46: Zoetis' Production Animal Vaccines, by Target Species, 2019
    • Table 47: Global Market for Animal Pharmaceutical Products, by Type, Through 2024
    • Table 48: Global Market for Animal Pharmaceutical Products, by Animal Group, Through 2024
    • Table 49: Global Market for Animal Pharmaceuticals, by Geographic Region, Through 2024
    • Table 50: Global Market Shares of Animal Pharmaceutical Product Suppliers, 2019
    • Table 51: Boehringer Ingelheim's Allergy and Respiratory Drugs, by Target Species
    • Table 52: Dechra Pharmaceuticals' Allergy and Respiratory Drugs, by Target Species
    • Table 53: Elanco's Allergy and Respiratory Drugs, by Target Species
    • Table 54: Heska's Allergy and Respiratory Drugs, by Target Species
    • Table 55: Huvepharma's Allergy and Respiratory Drugs, by Target Species
    • Table 56: Virbac's Allergy and Respiratory Drugs, by Target Species, 2019
    • Table 57: Zoetis' Allergy and Respiratory Drugs, by Target Species, 2019
    • Table 58: Bayer's Anti-Infective Drugs, by Target Species, 2019
    • Table 59: Boehringer Ingelheim's Anti-Infective Drugs, by Target Species
    • Table 60: Dechra Pharmaceuticals' Anti-Infective Drugs, by Target Species
    • Table 61: ECO Animal Health's Anti-Infective Drugs, by Target Species
    • Table 62: Elanco's Anti-Infective Drugs, by Target Species, 2019
    • Table 63: Merck's Anti-Infective Drugs, by Target Species, 2019
    • Table 64: Virbac's Anti-Infective Drugs, by Target Species
    • Table 65: Zoetis' Anti-Infective Drugs, by Target Species, 2019
    • Table 66: Aratana Therapeutics' Anti-Inflammatories and Analgesics, by Target Species
    • Table 67: Bayer Anti-Inflammatories and Analgesics, by Target Species
    • Table 68: Boehringer Ingelheim's Anti-Inflammatories and Analgesics, by Target Species
    • Table 69: Dechra Pharmaceuticals' Anti-Inflammatories and Analgesics, by Target Species
    • Table 70: Elanco's Anti-Inflammatories and Analgesics, by Target Species, 2019
    • Table 71: Merck's Anti-Inflammatories and Analgesics, by Target Species, 2019
    • Table 72: Vetoquinol's Anti-Inflammatories and Analgesics, by Target Species
    • Table 73: Zoetis' Anti-Inflammatories and Analgesics, by Target Species, 2019
    • Table 74: Aratana Therapeutics' Metabolic and Endocrine Drugs, by Target Species
    • Table 75: Bayer's Metabolic and Endocrine Drugs, by Target Species
    • Table 76: Boehringer Ingelheim's Metabolic and Endocrine Drugs, by Target Species
    • Table 77: Dechra Pharmaceuticals' Metabolic and Endocrine Drugs, by Target Species
    • Table 78: Merck's Metabolic and Endocrine Drugs, by Target Species, 2019
    • Table 79: Virbac's Metabolic and Endocrine Drugs, by Target Species
    • Table 80: Zoetis' Metabolic and Endocrine Drugs, by Target Species, 2019
    • Table 81: Bayer's Parasiticides, by Target Species, 2019
    • Table 82: Beaphar's Parasiticides, by Target Species
    • Table 83: Boehringer Ingelheim's Parasiticides, by Target Species, 2019
    • Table 84: ECO Animal Health's Parasiticides, by Target Species
    • Table 85: Elanco's Parasiticides, by Target Species, 2019
    • Table 86: Huvepharma Parasiticides, by Target Species
    • Table 87: Merck's Parasiticides, by Target Species, 2019
    • Table 88: Virbac's Parasiticides, by Target Species, 2019
    • Table 89: Zoetis' Parasiticides, by Target Species, 2019
    • Table 90: Boehringer Ingelheim's Psychotropic Medications, by Target Species
    • Table 91: Elanco's Psychotropic Medications, by Target Species
    • Table 92: Vetoquinol's Psychotropic Medications, by Target Species
    • Table 93: Zoetis' Psychotropic Medications, by Target Species
    • Table 94: Bayer's Other Pharmaceuticals, by Target Species
    • Table 95: Boehringer Ingelheim's Other Pharmaceuticals, by Target Species
    • Table 96: Dechra Pharmaceuticals' Other Pharmaceuticals, by Target Species
    • Table 97: Elanco's Other Pharmaceuticals, by Target Species
    • Table 98: HbO2 Therapeutics' Other Pharmaceuticals, by Target Species
    • Table 99: Merck's Other Pharmaceuticals, by Target Species
    • Table 100: Virbac's Other Pharmaceuticals, by Target Species
    • Table 101: Vetoquinol's Other Pharmaceuticals, by Target Species
    • Table 102: Zoetis' Other Pharmaceuticals, by Target Species, 2019
    • Table 103: Dental Pharmaceuticals, by Target Species and Provider
    • Table 104: Global Market for Animal Feed Additive Products, by Type, Through 2024
    • Table 105: Global Market for Feed Additives, by Animal Group, Through 2024
    • Table 106: Global Market for Animal Feed Additives, by Geographic Region, Through 2024
    • Table 107: Global Market Share of Animal Feed Additives Suppliers, 2019
    • Table 108: Adisseo's Amino Acids, by Target Species
    • Table 109: Ajinomoto's Amino Acids, by Target Species
    • Table 110: Boehringer Ingelheim's Amino Acids, by Target Species
    • Table 111: Evonik's Amino Acids, by Target Species
    • Table 112: Dechra Pharmaceuticals' Medicinal Additives, by Target Species
    • Table 113: ECO Animal Health Medicinal Additives, by Target Species
    • Table 114: Elanco's Medicinal Additives, by Target Species
    • Table 115: Huvepharma's Medicinal Additives, by Target Species
    • Table 116: Merck's Medicinal Additives, by Target Species
    • Table 117: Phibro's Medicinal Additives, by Target Species
    • Table 118: Zoetis' Medicinal Additives, by Target Species
    • Table 119: Adisseo (Bluestar) Nutritional Supplements, by Target Species
    • Table 120: Bayer's Nutritional Supplements, by Target Species
    • Table 121: BASF's Nutritional Supplements, by Target Species
    • Table 122: Beaphar's Nutritional Supplements, by Target Species
    • Table 123: Boehringer Ingelheim's Nutritional Supplements, by Target Species
    • Table 124: Dechra Pharmaceuticals' Nutritional Supplements, by Target Species
    • Table 125: DSM's Nutritional Supplements, by Target Species
    • Table 126: Elanco's Nutritional Supplements, by Target Species
    • Table 127: Evonik's Nutritional Supplements, by Target Species
    • Table 128: Heska's Nutritional Supplements, by Target Species
    • Table 129: Mosaic's Nutritional Supplements, by Target Species
    • Table 130: Vetoquinol's Nutritional Supplements, by Target Species
    • Table 131: Virbac's Nutritional Supplements, by Target Species
    • Table 132: Adisseo's Vitamins and Minerals, by Target Species
    • Table 133: BASF's Vitamins Aad Minerals, by Target Species
    • Table 134: Bayer's Vitamins and Minerals, by Target Species
    • Table 135: Beaphar's Vitamins and Minerals, by Target Species
    • Table 136: DSM's Vitamins and Minerals, by Target Species
    • Table 137: Merck's Vitamins and Minerals, by Target Species
    • Table 138: Zoetis' Vitamins and Minerals, by Target Species
    • Table 139: Global Market for Animal Diagnostics, by Type, Through 2024
    • Table 140: Global Market for Animal Diagnostic Products, by Animal Group, Through 2024
    • Table 141: Global Market for Animal Diagnostics, by Geographic Region, Through 2024
    • Table 142: Global Market Shares of Animal Diagnostics Suppliers Based on Competitor Revenues, 2019
    • Table 143: Bayer's Diagnostics, by Target Species
    • Table 144: Beaphar's Diagnostics, by Target Species
    • Table 145: Elanco's Diagnostics, by Target Species
    • Table 146: Heska's Diagnostics, by Target Species, 2019
    • Table 147: IDEXX's Diagnostics, by Target Species, 2019
    • Table 148: Merck's Diagnostics, by Target Species
    • Table 149: Virbac's Diagnostics, by Target Species, 2019
    • Table 150: Zoetis' Diagnostics, by Target Species, 2019
    • Table 151: Annual Distribution of U.S. Patents Granted on Animal Health Products, Jan. 1, 2000-Dec. 31, 2019
    • Table 152: Distribution of U.S. Patents on Animal Health Products, by Patent Holder's Country, Jan. 1, 1976-Dec. 31, 2019
    • Table 153: Distribution of U.S. Patents on Animal Health Products, by Patent Holder, Jan. 1, 1976-Dec. 31, 2019
    • Table 154: Competitor Market Position in Animal Therapeutics and Diagnostics, by Segment, 2019
    • Table 155: Ajinomoto: Financial Overview, FY 2018 and FY 2019
    • Table 156: Aratana Therapeutics: Financial Overview, 2017 and 2018
    • Table 157: BASF: Financial Overview, 2017 and 2018
    • Table 158: Bayer Animal Health: Financial Overview, 2017 and 2018
    • Table 159: Bluestar Adisseo: Financial Overview, 2017 and 2018
    • Table 160: Boehringer Ingelheim: Financial Overview, 2017 and 2018
    • Table 161: Dechra: Financial Overview, FY 2018 and FY 2019
    • Table 162: DSM: Financial Overview, 2017 and 2018
    • Table 163: Elanco: Financial Overview, 2017 and 2018
    • Table 164: Evonik: Financial Overview, 2017 and 2018
    • Table 165: Heska: Financial Overview, 2017 and 2018
    • Table 166: IDEXX: Financial Overview, 2017 and 2018
    • Table 167: Merck Animal Health: Financial Overview, 2017 and 2018
    • Table 168: Mosaic: Financial Overview, 2017 and 2018
    • Table 169: Virbac: Financial Overview, 2017 and 2018
    • Table 170: Zoetis: Financial Overview, 2017 and 2018
    • Table 171: Report Sources

List of Figures

  • Summary Figure: Global Market for Animal Therapeutics and Diagnostics, by Product Type, 2018-2024
    • Figure 1: Number of Veterinarians and Paraveterinarian Assistants, by Top 10 Countries, 2012, 2015 and 2018
    • Figure 2: Estimated Number of Veterinarians in the United States, by Gender*, 2010-2018
    • Figure 3: African Swine Fever Situation in Asia, August 2018 to date
    • Figure 4: Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals, 2010-2017
    • Figure 5: Global Market for Animal Therapeutics and Diagnostics, by Product Segment, 2018-2024
    • Figure 6: Growth in Global Market for Animal Therapeutics and Diagnostics, by Segment, 2019-2024
    • Figure 7: Global Market for Animal Therapeutics and Diagnostics, by Animal Group, 2018-2024
    • Figure 8: Global Market Shares of Animal Therapeutics and Diagnostics, by Animal Group, 2019
    • Figure 9: Global Market for Animal Therapeutics and Diagnostics, by Geographic Region, 2018-2024
    • Figure 10: Global Market Shares of Animal Therapeutics and Diagnostics, by Geographic Region, 2019
    • Figure 11: Global Market Shares of Animal Therapeutics and Diagnostics, by Select Country, 2019
    • Figure 12: Global Market Shares of Animal Therapeutics and Diagnostics, by Manufacturer Revenues, 2019
    • Figure 13: Global Market Shares of Animal Vaccines, by Animal Group, 2019
    • Figure 14: Global Market Shares of Animal Vaccines, by Geographic Region, 2019
    • Figure 15: Global Market Shares of Animal Vaccine Suppliers Based on Competitor Revenues, 2019
    • Figure 16: Boehringer Ingelheim's Companion Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 17: Elanco's Companion Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 18: Merck's Companion Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 19: Zoetis' Companion Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 20: Global Market for Companion Animal Vaccines, by Animal Species, 2018-2024
    • Figure 21: Global Revenues for Companion Animal Vaccines, by Type, 2018-2024
    • Figure 22: Boehringer Ingelheim's Production Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 23: Elanco's Production Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 24: Merck's Production Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 25: Zoetis' Production Animal Vaccines, Product Portfolio Distribution, by Target Species, 2019
    • Figure 26: Global Market for Production Animal Vaccines, by Animal Species, 2018-2024
    • Figure 27: Global Market for Production Animal Vaccines, by Type, 2018-2024
    • Figure 28: Global Market for Animal Pharmaceutical Products, by Type, 2018-2024
    • Figure 29: Global Market Shares of Animal Pharmaceutical Products, by Animal Group, 2019
    • Figure 30: Global Market Shares of Animal Pharmaceuticals, by Geographic Region, 2019
    • Figure 31: Global Market Shares of Animal Pharmaceutical Product Suppliers Based on Competitor Revenues, 2019
    • Figure 32: Leading Animal Allergy and Respiratory Drug Providers, Distribution of Sales, 2019
    • Figure 33: Virbac's Allergy and Respiratory Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 34: Zoetis' Allergy and Respiratory Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 35: Global Market for Allergy and Respiratory Products, by Animal Group, 2018-2024
    • Figure 36: Leading Animal Anti-Infective Drug Providers, Distribution of Sales, 2019
    • Figure 37: Bayer's Anti-Infective Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 38: Elanco's Anti-Infective Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 39: Merck's Anti-Infective Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 40: Zoetis' Anti-Infective Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 41: Global Market for Anti-Infectives, by Animal Group, 2018-2024
    • Figure 42: Leading Animal Anti-Inflammatory and Analgesic Drug Providers, Distribution of Sales, 2019
    • Figure 43: Elanco's Anti-Inflammatories and Analgesics, Product Portfolio Distribution, by Target Species, 2019
    • Figure 44: Merck's Anti-Inflammatories and Analgesics, Product Portfolio Distribution, by Target Species, 2019
    • Figure 45: Zoetis' Anti-Inflammatories and Analgesics, Product Portfolio Distribution, by Target Species, 2019
    • Figure 46: Global Market for Anti-Inflammatories and Analgesics, by Animal Group, 2018-2024
    • Figure 47: Leading Animal Metabolic and Endocrine Drug Providers, Distribution of Sales, 2019
    • Figure 48: Merck's Metabolic and Endocrine Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 49: Zoetis' Metabolic and Endocrine Drugs, Product Portfolio Distribution, by Target Species, 2019
    • Figure 50: Global Market for Metabolic Drugs, by Animal Group, 2018-2024
    • Figure 51: Leading Animal Parasiticide Drug Providers, Distribution of Sales, 2019
    • Figure 52: Bayer's Parasiticides: Product Portfolio Distribution, by Target Species, 2019
    • Figure 53: Boehringer Ingelheim's Parasiticides: Product Portfolio Distribution, by Target Species, 2019
    • Figure 54: Elanco's Parasiticides: Product Portfolio Distribution, by Target Species, 2019
    • Figure 55: Merck's Parasiticides: Product Portfolio Distribution, by Target Species, 2019
    • Figure 56: Virbac's Parasiticides: Product Portfolio Distribution, by Target Species, 2019
    • Figure 57: Zoetis' Parasiticides: Product Portfolio Distribution, by Target Species, 2019
    • Figure 58: Global Market for Parasiticides, by Animal Group, 2018-2024
    • Figure 59: Leading Animal Psychotropic Medication Providers, Distribution of Sales, 2019
    • Figure 60: Zoetis' Other Pharmaceuticals: Product Portfolio Distribution, by Target Species, 2019
    • Figure 61: Global Market for Other Pharmaceuticals, by Animal Group, 2018-2024
    • Figure 62: Global Market for Animal Feed Additive Products, by Type, 2018-2024
    • Figure 63: Global Market Share of Feed Additives, by Animal Group, 2019
    • Figure 64: Global Market Share of Animal Feed Additives, by Geographic Region, 2019
    • Figure 65: Global Market Share of Animal Feed Additives Suppliers, 2019
    • Figure 66: Global Market for Amino Acids, by Animal Group, 2018-2024
    • Figure 67: Zoetis' Medicinal Additives: Product Portfolio Distribution, by Target Species, 2019
    • Figure 68: Global Market for Medicinal Feed Additives, by Animal Group, 2018-2024
    • Figure 69: Global Market for Nutritional Supplements, by Animal Group, 2018-2024
    • Figure 70: Global Market for Vitamins and Minerals, by Animal Group, 2018-2024
    • Figure 71: Global Market for Animal Diagnostics, by Type, 2018-2024
    • Figure 72: Global Market Shares of Animal Diagnostics, by Animal Group, 2019
    • Figure 73: Global Market Shares of Animal Diagnostics, by Geographic Region, 2019
    • Figure 74: Global Market Share of Animal Diagnostics, by Country, 2019
    • Figure 75: Global Market Shares of Animal Diagnostic Suppliers Based on Competitor Revenues, 2019
    • Figure 76: Heska's Diagnostics: Product Portfolio Distribution, by Target Species, 2019
    • Figure 77: IDEXX's Diagnostics: Product Portfolio Distribution, by Target Species, 2019
    • Figure 78: Virbac's Diagnostics: Product Portfolio Distribution, by Target Species, 2019
    • Figure 79: Zoetis' Diagnostics: Product Portfolio Distribution, by Target Species, 2019
    • Figure 80: Zoetis' Feline Diagnostics: Product Portfolio Distribution, by Disease Target, 2019
    • Figure 81: Zoetis' Canine Diagnostics: Product Portfolio Distribution, by Disease Target, 2019
    • Figure 82: Zoetis' Equine Diagnostics: Product Portfolio Distribution, by Disease Target, 2019
    • Figure 83: Zoetis' Ruminant Diagnostics: Product Portfolio Distribution, by Disease Target, 2019
    • Figure 84: Zoetis' Swine Diagnostics: Product Portfolio Distribution, by Disease Target, 2019
    • Figure 85: Zoetis' Poultry/Avian Diagnostics: Product Portfolio Distribution, by Disease Target, 2019
    • Figure 86: Global Market for Rapid Diagnostic Tests, by Animal Group, 2018-2024
    • Figure 87: Global Market for Rapid Diagnostics, by Test Type (Veterinary Applications), 2018-2024
    • Figure 88: Global Market for Diagnostic Analyzers and Consumables, by Animal Group, 2018-2024
    • Figure 89: Global Market for Diagnostic Analyzers and Consumables, by Test Type (Veterinary Applications), 2018-2024
    • Figure 90: Global Market for Diagnostic Imaging Equipment and Related Materials, by Animal Group, 2018-2024
    • Figure 91: Annual Distribution of U.S. Patents Granted on Animal Health Products, Jan. 1, 2000-Dec. 31, 2019
    • Figure 92: Distribution of U.S. Patents on Animal Health Products, by Patent Holder's Country, Jan. 1, 1976-Dec. 31, 2019
    • Figure 93: Distribution of U.S. Patents on Animal Health Products, by Patent Holder, Jan. 1, 1976-Dec. 31, 2019